This project team will create a White Paper with recommendations for listings to include in Clinical Study Reports based on shared learning from cross-industry participants, to address changes in data availability over time.
White Paper providing recommendations for listings to include CSRs and submissions (if any), with a summary of example alternatives to static listings.
Q42021
Project Members
Organisation
Anna Leath
Eli Lilly
Kim Musgrave
Amgen
Maria Dalton
GSK
Mary Nilsson
Eli Lilly
Raj Phadtare
Corvus Pharma
Q3/42021
White Paper published on the PHUSE website. Also investigating publishing inPharmaceutical Statistics,and submitting toPharmaSUG2022.